How Long Do Wegovy Pens Last?

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy pens contain 2 milliliters of semaglutide solution, but how long a single pen lasts depends entirely on your prescribed dose and how often you inject each week. Understanding pen longevity helps you plan refills and anticipate costs before switching to a more affordable compounded option.

How Long Does One Wegovy Pen Supply Last?

A standard Wegovy pen delivers 2 milliliters of semaglutide and lasts approximately four weeks for patients on maintenance doses. During the initial titration phase, when doses start low and gradually increase, a single pen may stretch across five to six weeks because each weekly injection uses less medication. Once you reach your target dose—typically 1.7 or 2.4 milligrams per week—pen consumption stabilizes at one pen every 28 days.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Semaglutide Pen Titration Schedule and Duration

Most patients follow a four-week titration protocol starting with 0.25 milligrams weekly, then increasing by 0.25 milligrams each week until reaching their maintenance dose. During this escalation period, one Wegovy pen can last six to eight weeks because you're using less medication in the earlier injections. The first pen of your treatment journey outlasts subsequent pens significantly, which some patients find financially relieving when facing brand-name costs.

After you complete titration and settle into your maintenance dose, typically between weeks 5 and 16, your pen consumption becomes predictable. Most people on 1.7 or 2.4 milligrams weekly will use one pen every month thereafter. Tracking when you started and which dose level you're currently on helps you anticipate refill needs and budget accordingly.

Brand-Name Wegovy Costs Versus Compounded Semaglutide Pricing

Wegovy pens at retail pharmacies typically cost between $900 and $1,350 per pen without insurance coverage, translating to roughly $10,800 to $16,200 annually for maintenance-dose patients. Insurance coverage varies widely; many plans classify Wegovy as a lifestyle medication and deny coverage entirely, leaving patients with full out-of-pocket expenses. Even with manufacturer coupons or patient assistance programs, the cumulative cost of pens across a full year remains substantial.

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan, regardless of your dose strength—your dose may need to go up, but your price won't. This flat monthly pricing eliminates the financial uncertainty of buying individual pens and allows you to budget predictably. PlexusDx serves all 50 states without requiring insurance or membership fees, making it accessible to patients who face coverage denials or prefer cash-pay options.

Personalizing Your Semaglutide Treatment With Genetic Insights

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The genetic test adds $298 and provides 150+ personalized insights into your peptide-pathway predispositions. Patients with specific genetic profiles may achieve their weight-loss goals faster or on lower doses, meaning pens last longer and monthly costs remain stable despite potentially needing fewer total injections. This precision approach transforms semaglutide therapy from a one-size-fits-all protocol into a truly personalized treatment plan.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Do Wegovy pens last the full month on every dose?

No. During the four-week titration phase when doses increase weekly, the first pen may last five to six weeks. Once you reach your target maintenance dose, expect one pen per month. Your actual timeline depends on your specific dose strength.

Why does compounded semaglutide from PlexusDx cost less than brand-name Wegovy?

Compounded medications are formulated in licensed 503A pharmacies at lower production costs than brand-name manufacturers. PlexusDx eliminates middleman markups and pharmaceutical company overhead, passing those savings directly to patients at a flat $189 monthly rate starting price.

Is compounded semaglutide from PlexusDx as effective as Wegovy?

Yes. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies using the same active ingredient as brand-name Wegovy. The medication itself is chemically identical; the difference is pricing and access, not efficacy.

Can genetic testing help me use my semaglutide pen more efficiently?

Yes. The PlexusDx Precision Peptide Genetic Test ($298) identifies how your body responds to semaglutide based on variants in GIPR and FTO, and MC4R genes. Patients with certain genetic profiles may reach their weight-loss goals on lower doses, extending pen duration and maximizing value.

Do I need insurance to access PlexusDx semaglutide injections?

No. PlexusDx serves all 50 states without requiring insurance or membership fees. HSA and FSA accounts are accepted for payment, making semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan accessible to uninsured and underinsured patients.

Related Reading

• Do Genetics Affect How Long My Reproductive Years Will Last
• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.